Manufacturer

Country

Certificates

Registration Date	16 Nov 2016
Share

Macugen

(0)

Medicine Pharmaceuticals Product Number : 68782-001-02

Ophthalmologic Agent

Drug Information

Generic

Pegaptanib

NDC Code

68782-001-02

Drug Class

Anti-angiogenic ophthalmic agents

Therapeutic Class

Ophthalmologic Agent

Dosage form

Solution

Route of Administration

INTRAVITREAL

Therapeutic Area

1.Age-related macular degeneration

Indication

Macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration.

Benefit

After one year of treatment, about 70% of the patients treated with Macugen 0.3 and 1 mg lost less than 15 letters in the eye test compared with about 55% of those who received the sham injection. The 3-mg dose did not bring any additional benefit. This improvement lasted for two years in patients who were given Macugen.